Puma Biotechnology, Inc. (PBYI) research: valuation against peers, fundamentals over time, risk and news coverage
ChartVs peersValuationValue mapQuartersScaleMarginsTrajectoryCash qualityPer shareReinvestmentBalance sheetStreetRiskSeasonalityOur coverage
PBYI
Puma Biotechnology, Inc.USD
9.52
+1.38% today
Market cap
—
P/E trailing
—
P/E forward
—
EV/EBITDA
—
Op margin
—
Rev growth
—
Div yield
—
Beta
—
Price navigator — PBYI
No data in this window.
INDY NEWS coverage of PBYI1
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- SPECIAL REPORTNEUTRALInsider Sales Cluster Across Health, Industrial and Tech Names
A wave of insider stock sales this week included Natera's executive chairman selling $34.8 million and Integer Holdings' CHRO selling $3.98 million, alongside smaller purchases at Terawulf and Mach Natural Resources.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.